Communication, recruitment and enrolment in the preventative and therapeutic phase I clinical trial against HIV/AIDS based on the recombinant HIV-1 Tat protein

References

• Baigis , J. , Francis , M.E. and Hoffman , M. 2003 . Cost-effectiveness analysis of recruitment strategies in a community-based intervention study of HIV-infected persons . AIDS Care , 15 : 717 – 728 .
   PubMed Web of Science ®Google Scholar
• Bellino , S. , Francavilla , V. , Longo , O. , Tripiciano , A. , Paniccia , G. , Arancio , A. and … Ensoli , B. 2009 . Parallel conduction of the phase I preventive and therapeutic trials based on the Tat vaccine candidate . Review of Recent Clinical Trials , 4 : 195 – 204 .
   PubMedGoogle Scholar
• Bellotti , G.G. , & Bellani , M.L. 1997 . Il counseling nell'infezione da HIV e nell'AIDS [Counselling in the HIV infection and AIDS] (pp. 649 – 666 ). Milan : McGraw-Hill .
   Google Scholar
• Buchbinder , S.P. , Metch , B. , Holte , S.E. , Scheer , S. , Coletti , A. and Vittinghoff , E. 2004 . Determinants of enrollment in a preventive HIV vaccine trial: Hypothetical versus actual willingness and barriers to participation . Journal of Acquired Immune Deficiency Syndrome , 36 : 604 – 612 .
   PubMed Web of Science ®Google Scholar
• Caputo , A. , Gavioli , R. , Bellino , S. , Longo , O. , Tripiciano , A. , Francavilla , V. and Ensoli , B. 2009 . HIV-1 Tat-based vaccines: an overview and perspectives in the field of HIV/AIDS vaccine development . International Reviews of Immunology , 28 : 285 – 334 .
   PubMed Web of Science ®Google Scholar
• Colfax , G. , Buchbinder , S. , Vamshidar , G. , Celum , C. , McKirnan , D. , Neidig , J. and … Bartholow , B. 2005 . Motivations for participating in an HIV vaccine efficacy trial . Journal of Acquired Immune Deficiency Syndrome , 39 : 359 – 364 .
   PubMed Web of Science ®Google Scholar
• de Mei , B , Luzi , A.M. and Gallo , P. 1998 . Proposta per un percorso formativo sul counselling integrato. Annales . Istituto Superiore di Sanità , 34 : 529 – 539 .
   PubMedGoogle Scholar
• Ensoli , B. , Fiorelli , V. , Ensoli , F. , Cafaro , A. , Titti , F. , Butto , S. and … Garaci , E. 2006 . Candidate HIV-1 Tat vaccine development: From basic science to clinical trials . AIDS , 20 : 2245 – 2261 .
   PubMed Web of Science ®Google Scholar
• Ensoli , B. , Fiorelli , V. , Ensoli , F. , Lazzarin , A. , Visintini , R. , Narciso , P. and … Garaci , E. 2008 . The therapeutic phase I trial of the recombinant native HIV-1 Tat protein . AIDS , 22 : 2207 – 2209 .
   PubMed Web of Science ®Google Scholar
• Gross , C.P. , Mallory , R. , Heiat , A. and Krumholz , H.M. 2002 . Reporting the recruitment process in clinical trials: Who are these patients and how did they get there? . Annals of Internal Medicine , 137 : 10 – 16 .
   PubMed Web of Science ®Google Scholar
• Haidich , A.B. and Ioannidis , J.P. 2001 . Patterns of patient enrollment in randomized controlled trials . Journal of Clinical Epidemiology , 54 : 877 – 883 .
   PubMed Web of Science ®Google Scholar
• Halpern , S.D. , Metzger , D.S. , Berlin , J.A. and Ubel , P.A. 2001 . Who will enroll? Predicting participation in a phase II AIDS vaccine trial . Journal of Acquired Immune Deficiency Syndrome , 27 : 281 – 288 .
   PubMed Web of Science ®Google Scholar
• Longo , O. , Tripiciano , A. , Fiorelli , V. , Bellino , S. , Scoglio , A. , Collacchi , B. and … Ensoli , B. 2009 . Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up . Vaccine , 27 : 3306 – 3312 .
   PubMed Web of Science ®Google Scholar
• Mills , E. , Wilson , K. , Rachlis , B. , Griffith , L. , Wu , P. , Guyatt , G. and Cooper , C. 2006 . Barriers to participation in HIV drug trials: A systematic review . Lancet Infectious Disease , 6 : 32 – 38 .
   PubMed Web of Science ®Google Scholar
• Sheon , A.R. , Wagner , L. , McElrath , M.J. , Keefer , M.C. , Zimmerman , E. , Israel , H. and … Fast , P. 1998 . Preventing discrimination against volunteers in prophylactic HIV vaccine trials: Lessons from a phase II trial . Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology , 19 : 519 – 526 .
   PubMedGoogle Scholar
• Silverman , W.A. and Altman , D.G. 1996 . Patients’ preferences and randomised trials . Lancet , 347 : 171 – 174 .
   PubMed Web of Science ®Google Scholar
• Starace , F. , Wagner , T.M. , Luzi , A.M. , Cafaro , L. , Gallo , P. and Rezza , G. 2006 . Knowledge and attitudes regarding preventative HIV vaccine clinical trials in Italy: Results of a national survey . AIDS Care , 18 : 66 – 72 .
   PubMed Web of Science ®Google Scholar
• Thapinta , D. , Jenkins , R.A. , Morgan , P.A. , Chiu , J. , Boenim , W. , Bussaratid , V. and … Thongchareon , P. 2002 . Recruiting volunteers for a multisite phase I/II HIV preventive vaccine trial in Thailand . Journal of Acquired Immune Deficiency Syndrome , 30 : 503 – 513 .
   PubMed Web of Science ®Google Scholar